Mangoceuticals (MGRX) Enterprise Value (2023 - 2025)
Mangoceuticals (MGRX) has disclosed Enterprise Value for 3 consecutive years, with -$1.5 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 1884.69% to -$1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, down 1884.69% year-over-year, with the annual reading at -$1.5 million for FY2025, 1884.69% down from the prior year.
- Enterprise Value hit -$1.5 million in Q4 2025 for Mangoceuticals, down from -$18681.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$36.0 in Q1 2024 to a low of -$1.5 million in Q4 2025.
- Historically, Enterprise Value has averaged -$366693.0 across 3 years, with a median of -$93154.0 in 2024.
- Biggest five-year swings in Enterprise Value: surged 92.59% in 2024 and later plummeted 262725.0% in 2025.
- Year by year, Enterprise Value stood at -$16942.0 in 2023, then crashed by 352.58% to -$76676.0 in 2024, then tumbled by 1884.69% to -$1.5 million in 2025.
- Business Quant data shows Enterprise Value for MGRX at -$1.5 million in Q4 2025, -$18681.0 in Q3 2025, and -$119142.0 in Q2 2025.